Sanofi ends partnership with Lexicon to develop diabetes drug
FILE PHOTO: A logo of Sanofi is pictured during the company’s shareholders meeting in Paris, France, April 30, 2019. REUTERS/Benoit…
Bristol-Myers releases mixed Opdivo lung cancer results
FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage,…
Deployment of second Ebola vaccine would not be quick fix, experts warn
GOMA, Democratic Republic of Congo (Reuters) – The resignation of Congo’s health minister in the midst of the country’s worst…
Multiple sclerosis drug helps Biogen beat Wall St. profit expectations
(Reuters) – Biogen Inc reported better-than-expected second quarter profit and raised its 2019 earnings forecast on Tuesday, driven by higher…
Biohaven’s treatment for Lou Gehrig’s disease fails to win FDA nod
FILE PHOTO: The logo for Biohaven Pharmaceutical Holding Company is displayed on a screen during the company’s IPO on the…
Gilead invests $5 billion to deepen ties with biotech Galapagos
(Reuters) – U.S. antiviral drugmaker Gilead Sciences (GILD.O) will invest $5.1 billion in a major expansion of its partnership with…
Eton’s conjunctivitis treatment fails to win FDA nod; shares tumble
(Reuters) – Eton Pharmaceuticals Inc said on Friday that the U.S. Food and Drug Administration declined to approve its treatment…
J&J faces U.S. criminal probe related to baby powder – Bloomberg
The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE)…
Sarepta surges after Pfizer gene therapy data raises safety concerns
(Reuters) – Shares of Sarepta Therapeutics Inc (SRPT.O) surged 15% on Friday after some safety concerns were raised in a…
Conatus Pharma to explore options as liver disease drug fails trial
(Reuters) – Conatus Pharmaceuticals Inc said on Monday it plans to explore options and implement a restructuring plan after its…
FDA approves drug for loss of sexual desire in women
(Reuters) – The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals’ drug to restore sexual desire in…
Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma
(Reuters) – Pfizer Inc on Monday said it would buy Array Biopharma Inc for $10.64 billion in cash, a deal…
VBI’s shares plunge after hep B vaccine fails secondary goal in late-stage trial
(Reuters) – VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis…
Bluebird prices gene therapy at 1.58 million euros over 5 years
(Reuters) – Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78…
Health Canada to allow some edible cannabis products starting mid-December
FILE PHOTO: Cannabis plants fill a room in an aquaponics grow operation by licensed marijuana producer Green Relief in Flamborough,…
Enanta’s lung infection therapy succeeds in mid-stage trial
(Reuters) – Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal…
Insys to pay $225 million, unit to plead guilty to settle U.S. opioid charges
(Reuters) – Insys Therapeutics Inc agreed to pay $225 million and an operating unit agreed to plead guilty to five…
From prison, ‘Pharma Bro’ Martin Shkreli sues ex-colleagues for $30 million
NEW YORK (Reuters) – Martin Shkreli, the pharmaceutical entrepreneur serving a seven-year prison term for fraud, on Friday sued three…
‘Smart’ hearing aids would identify speakers in crowded room
(Reuters Health) – People wearing hearing aids often struggle to differentiate between speakers in a crowded environment, but a small…
Patients’ drug costs surge for some neurologic conditions
(Reuters Health) – Many patients with neurologic disorders like multiple sclerosis, epilepsy and Parkinson’s disease have seen steep increases in…
FDA approves expanded label for Regeneron/Sanofi’s cholesterol drug
(Reuters) – The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc’s cholesterol drug Praluent as a treatment…
Medicare offers to partially raise payment for cancer CAR-Ts
(Reuters) – The U.S. Centers for Medicare and Medicaid Services will slightly increase coverage for expensive CAR-T cell therapies administered…
Catalent seeks slice of gene therapy market with Paragon buy
(Reuters) – Contract drugmaker Catalent Inc said on Monday it would buy privately held Paragon Bioservices Inc for $1.2 billion…
U.S., China agree to establish trade deal enforcement offices: Mnuchin
WASHINGTON (Reuters) – The United States and China have largely agreed on a mechanism to police any trade agreement they…
Zogenix’s seizure drug filing fails to pass U.S. FDA scrutiny
(Reuters) – The U.S. Food and Drug Administration on Monday refused to fully review the marketing application for Zogenix Inc’s…
Biotech crops still a sticking point in U.S.-China trade deal: sources
WASHINGTON (Reuters) – China’s lengthy approval process for genetically modified crops remains a sticking point in talks to end the…
Oklahoma drops several claims in opioid case against J&J, Teva
(Reuters) – Oklahoma’s attorney general on Thursday had dropped all but a single claim against Johnson & Johnson and Teva…
OxyContin maker Purdue agrees to settle Oklahoma opioid case: source
(Reuters) – Purdue Pharma LP has agreed to settle a lawsuit by the state of Oklahoma accusing the OxyContin painkiller…
FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes
(Reuters) – The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals…
Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value
CHICAGO/TOKYO (Reuters) – Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease…
Amarin’s Vascepa cuts occurrence of serious heart problems 30 percent: study
(Reuters) – A high dose of Amarin Corp’s Omega-3 drug Vascepa significantly reduced the occurrence of first and subsequent heart…
FDA chief tough on e-cigs steps down in surprise resignation
WASHINGTON (Reuters) – U.S. Food and Drug Administration Commissioner Scott Gottlieb said on Tuesday that he plans to step down…
Exclusive: OxyContin maker Purdue Pharma exploring bankruptcy – sources
(Reuters) – OxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address potentially significant liabilities from roughly 2,000…
U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug
(Reuters) – U.S. Senator Bernie Sanders this week urged regulators to allow pharmacies and manufacturers to resume distributing unbranded, lower-cost…
Novartis gene therapy would be cost effective up to $900,000: U.S. group
(Reuters) – An experimental gene therapy for spinal muscular atrophy (SMA) developed by Swiss drugmaker Novartis AG would be worth…
As medical costs mount, Japan to weigh cost-effectiveness in setting drug prices
TOKYO (Reuters) – Japanese doctor Yasushi Goto remembers prescribing the cancer drug Opdivo to an octogenarian and wondering whether taxpayers…
U.S. jury orders Takeda to pay Bayer $155 million over hemophilia drug
(Reuters) – A U.S. jury has ordered Takeda Pharmaceutical Co’s Baxalta unit to pay Bayer AG $155.19 million for infringing…
U.S. jury orders Takeda to pay Bayer $155 million over hemophilia drug
(Reuters) – A U.S. jury has ordered Takeda Pharmaceutical Co’s Baxalta unit to pay Bayer AG $155.19 million for infringing…
FDA approves cheaper Botox rival to treat frown lines
(Reuters) – An injection that makes forehead wrinkles disappear is set to rival Allergan’s Botox after U.S. regulators approved Evolus…
Insys founder ran bribe scheme to push opioid: U.S. prosecutor
BOSTON (Reuters) – Insys Therapeutics Inc’s one-time billionaire founder directed a vast scheme to bribe doctors to prescribe an addictive…
Swiss team develop ‘microswimmer’ robot to deliver drugs through the body
LONDON (Reuters) – – A tiny sliver of elastic material swims along inside a narrow tube, coiling up and changing…
J&J raises U.S. prices on around two dozen drugs
NEW YORK (Reuters) – Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the…
U.S. FDA approves Alexion Pharma’s blood disorder drug
(Reuters) – The U.S. Food and Drug Administration has approved Alexion Pharmaceuticals Inc’s blood disorder drug Ultomiris, the pharma regulator’s…
BrainStorm gets FDA okay for stem cell trial in MS patients
TEL AVIV (Reuters) – BrainStorm Cell Therapeutics Inc has received approval from the U.S. Food and Drug Administration to begin…
Evofem shares surge as contraceptive gel meets late-stage trial goal
(Reuters) – Shares of Evofem Biosciences Inc jumped as much as 38 percent on Monday after its birth control gel…
Physician assistant faces U.S. trial over Insys opioid kickbacks
(Reuters) – A former physician assistant is set to face trial in New Hampshire on Wednesday over charges he accepted…
Gilead Sciences snares Roche veteran O’Day as CEO
(Reuters) – Drugmaker Gilead Sciences Inc on Monday named Roche Holding AG’s Daniel O’Day as its new chief executive, tapping…
Johnson & Johnson’s multiple myeloma drug reduces risk of death in late-stage study
FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake (Reuters) –…
Congo approves clinical trials for Ebola treatments
KINSHASA (Reuters) – Congolese authorities have authorized clinical trials for four experimental Ebola treatments, which will allow researchers to collect…
BioMarin sets stage early for hemophilia cure off-Broadway
(This version of the November 21st story has been refiled to show in paragraph 23 that Sangamo Therapeutics has six…
U.S. regulators snip red tape for medical devices to curb opioid crisis
(Reuters) – Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling…
Sanofi drug Dupixent wins FDA approval to treat asthma
(Reuters) – France’s Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration…
EMA committee recommends restrictions on fluoroquinolone, quinolone antibiotics
(Reuters) – The European Medicines Agency’s risk assessment committee has recommended restrictions on the use of broad-spectrum antibiotics fluoroquinolone and…
Insmed’s treatment-resistant lung disease drug gets FDA approval
(Reuters) – The U.S. Food and Drug Administration on Friday approved Insmed Inc’s lead drug to treat a rare, chronic…
Defibrillator vest fails test because many heart attack survivors wouldn’t wear it
(Reuters Health) – Patients who have just survived a heart attack and consequently have a dangerously-weak heart face a high…
Drug shortages may add $230 million to annual U.S. drug costs
(Reuters Health) – Prescription drug shortages may drive up prices twice as much as they would rise with medicines in…
EU approves fifth copy of AbbVie’s $18 billion drug Humira
LONDON (Reuters) – Europe has approved a fifth copy of AbbVie’s $18-billion-a-year biologic drug Humira – the world’s best-selling prescription…
AstraZeneca plots China robot offensive to counter price cuts
WUXI, China/LONDON (Reuters) – With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients…
U.S. regulator approves Teva migraine drug, shares rise
(Reuters) – Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after the…
Akcea Therapeutics to cut about 10 percent of workforce
(Reuters) – Akcea Therapeutics Inc said on Thursday it planned to cut its workforce by about 10 percent after the…